Safety and efficacy of transcatheter closure of ruptured sinus of Valsalva aneurysm
10.3760/cma.j.issn.0253-3758.2018.10.007
- VernacularTitle: 经导管封堵主动脉窦瘤破裂的安全性和有效性
- Author:
Jiawang XIAO
1
;
Meina NIU
;
Qiguang WANG
;
Duanzhen ZHANG
;
Xiumin HAN
;
Po ZHANG
;
Chunsheng CUI
;
Xianyang ZHU
Author Information
1. Department of Congenital Heart Disease, General Hospital of Shenyang Military Command, Institute of Cardiovascular Disease of People's Liberation Army, Shenyang 110016, China
- Publication Type:Journal Article
- Keywords:
Treatment outcome;
Aortic sinus aneurysm;
Transcatheter closure
- From:
Chinese Journal of Cardiology
2018;46(10):799-803
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of transcatheter closure of ruptured sinus of Valsava aneurysm(RSVA).
Methods:A total of 33 RSVA patients underwent transcatheter closure from January 2006 to March 2017 in our hospital were included in this retrospective study. The RSVA was diagnosed by echocardiography.Different type of occluders were applied for transcatheter closure based on the aortography results. All the patients were followed up after the procedure.
Results:The patients were (37.6±12.1) years old,and the male patients accounted for 78.8%(26 cases).RSVA from right coronary sinus was found in 25 patients,and draining chamber was right atrium in 13 cases, right ventricle in 12 cases. RSVA from noncoronary sinus was diagnosed in 8 patients,and the draining chamber was right atrium. Aortography defined the narrowest diameter at the rupture site was (6.4±1.7)mm. The ratio of Qp/Qs was 2.2±0.5,and the mean pressure of pulmonary artery was 24.0(21.2,33.7)mmHg(1 mmHg=0.133 kPa). One patient developed serious occluder related aortic regurgitation and underwent surgery, transcatheter closure was successfully performed in 32 patients. The success rate of transcatheter closure was 97.0%. Two types of device were used in the study including small-waist double-disk ventricular septal defect(VSD) occluders in 20 cases and patent ductus arteriosus(PDA) occluders in 12 cases. During a median follow-up of 73.5(28.3,89.5) months, there were no infective endocarditis, residual shunt, thrombosis, device displacement,serious aortic regurgitation, serious arrhythmia or death.At the last follow-up, the left atrial diameter((37.4±6.5) mm vs. (41.5±5.3)mm,P<0.01),right atrial diameter((42.4±3.0) mm vs. (48.5±6.0)mm,P<0.01), right ventricular diameter((22.2±3.8) mm vs. (27.7±7.2)mm,P<0.01) and left ventricular end-diastolic diameter((51.3±4.9) mm vs.(55.0±4.3)mm,P<0.01)measured by echocardiography were all smaller than pre-procedural level.
Conclusion:Transcatheter closure of RVSA is a safe and effective strategy and associated with a good long-term outcome.
